[1]. [1]Ito K, Higuchi M, Kada T, et al. CT of acquired abnormalities of the portal venous system. Radiographics. 1997;17:897–917. MEDLINE
[2]. [2]Wakisaka M, Mori H, Kiyosue H, Kamegawa T, Uragami S. Septic thrombosis of the portal vein due to peripancreatic ligamental abscess. Eur Radiol. 1999;9:90–92. MEDLINE |
CrossRef
[3]. [3]Jung AY, Lee JM, Choi SH, et al. Computed tomography features of an intraductal polypoid mass: differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma. J Comput Assist Tomogr. 2006;30:18–24. MEDLINE |
CrossRef
[4]. [4]Sidhu PS, Shaw AS, Ellis SM, Karani JB, Ryan SM. Microbubble ultrasound contrast in the assessment of hepatic artery patency following liver transplantation: role in reducing frequency of hepatic artery arteriography. Eur Radiol. 2004;14:21–30. MEDLINE |
CrossRef
[5]. [5]Belli L, Magistretti G, Puricelli GP, et al. Arteritis following intra-arterial chemotherapy for liver tumors. Eur Radiol. 1997;7:323–326. MEDLINE |
CrossRef
[6]. [6]Tarhan NC, Coskun M, Kayahan EM, Yildirim E, Yucel E. Regression of abdominal visceral aneurysms in polyarteritis nodosa: CT findings. Am J Roentgenol. 2003;180:1617–1619.
[7]. [7]Schick C, Ritter RG, Balzer JO, Thalhammer A, Vogl TJ. Hepatic artery aneurysm: treatment options. Eur Radiol. 2004;14:157–159. MEDLINE |
CrossRef
[8]. [8]Coakley FV, O’Reilly EM, Schwartz LH, Panicek DM, Castellino RA. Non-Hodgkin lymphoma as a cause of intrahepatic periportal low attenuation on CT. J Comput Assist Tomogr. 1997;21:726–728. MEDLINE |
CrossRef
[9]. [9]Kim M, Lyu C, Jin Y, Yoo H. Langerhans’ cell histiocytosis as a cause of periportal abnormal signal intensity on MRI. Abdom Imaging. 1999;24:373–377. MEDLINE |
CrossRef
[10]. [10]Fenton LZ, Foreman N, Wyatt-Ashmead J. Diffuse, retroperitoneal mesenteric and intrahepatic periportal plexiform neurofibroma in a 5-year-old boy. Pediatr Radiol. 2001;31:637–639. MEDLINE |
CrossRef
[11]. [11]Levy AD, Rohrmann CA, Murakata LA, Lonergan GJ. Caroli's disease: radiologic spectrum with pathologic correlation. Am J Roentgenol. 2002;179:1053–1057.
[12]. [12]Guy F, Cognet F, Dranssart M, et al. Caroli's disease: magnetic resonance imaging features. Eur Radiol. 2002;12:2730–2736. MEDLINE
[13]. [13]Ernst O, Gottrand F, Calvo M, et al. Congenital hepatic fibrosis: findings at MR cholangiopancreatography. AJR Am J Roentgenol. 1998;170:409–412.
[14]. [14]Hatzidakis AA, Gogas C, Papanikolaou N, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber disease). Eur Radiol. 2002;12(Suppl. 3):S51–S55.
[15]. [15]Bader TR, Beavers KL, Semelka RC. MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology. 2003;226:675–685. MEDLINE |
CrossRef
[16]. [16]Lawson TL, Thorsen MK, Erickson SJ, et al. Periportal halo: a CT sign of liver disease. Abdom Imaging. 1993;18:42–46. MEDLINE |
CrossRef
[17]. [17]Siegel MJ, Herman TE. Periportal low attenuation at CT in childhood. Radiology. 1992;183:685–688. MEDLINE
[18]. [18]Hamer OW, Aguirre DA, Casola G, Sirlin CB. Imaging features of perivascular fatty infiltration of the liver: initial observations. Radiology. 2005;237:159–169. MEDLINE |
CrossRef
[19]. [19]Salmonson EC, Lundstedt C, Holmin T, Hagerstrand I. Focal periportal liver steatosis. Abdom Imaging. 1993;18:39–41. MEDLINE |
CrossRef